Skip to content

HbA1c verlaging voorafgaand aan een operatie

HbA1c lowering before surgery in poorly controlled diabetes mellitus; a pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON29027
Enrollment
20
Registered
2017-04-12
Start date
2017-06-01
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus Surgery Anaesthesia HbA1c

Interventions

Patients willing to participate and meeting the in- and exclusion criteria will be referred to the in-hospital diabetes nurse (IHDN). The IHDN will contact the patient by phone and evaluate the curren

Sponsors

Academic Medical Centre, Amsterdam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Diagnosis of DM type 2 at least 3 months prior to the screening - Adult patients, age 18-80 years inclusive - HbA1c >7% (53 mmol/mol) as measured at the pre-assessment clinic - Scheduled for elective surgery - Willing and able to provide written informed consent

Exclusion criteria

Exclusion criteria: - Emergency surgery or scheduled surgery < 3 weeks - Palliative oncological surgery - Underlying condition that does not allow patients to participate in the study

Design outcomes

Primary

MeasureTime frame
The main outcome parameter is whether it is possible to lower HbA1c > 1mmol/mol in the participating subjects or not.

Secondary

MeasureTime frame
As secondary outcome we will ask the patient to perform a fasting plasma glucose fingerstick measurement in the week of study inclusion and on the day of surgery. Also, complications will be registered for evaluation, although this study will to assess any relation between HbA1c and complications.

Contacts

Public ContactJ. Hermanides
J.Hermanides@amc.uva.nl0031-205669111

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)